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SUMMARY
The genetic and biochemical basis of ampicillin resistance amongst the aerobic
Gram-negative commensal faecal flora of healthy volunteers in South Africa has
been determined. Amongst 608 ampicillin resistant strains isolated from 320 of the
participants, 158 were able to transfer their ampicillin resistant determinants into
Escherichia coli K-12 J62-2. Iso-electric focusing of the /3-lactamases, extracted
from the transconjugants, demonstrated that ampicillin resistance resulted from
the presence of the TEM- 1, TEM-2 and SHV-i /3-lactamases in 94 3 %, 2 5% and
32% of isolates respectively. Endonuclease restriction digests of the plasmids
isolated from the transconjugants showed that the /,-lactamase genes were present
on a wide variety of plasmid types; 101 distinct plasmid endonuclease restriction
patterns were identified. Transferable ampicillin resistance was associated with
resistance to other antibiotics at the following frequencies: trimethoprim (48 7 %),
streptomycin (35 4 %), tetracycline (27-2 %), spectinomycin (9-5 %), chloram-
phenicol (3 2%) and gentamicin (1i3 %). One antibiotic resistance pattern,
ampicillin and trimethoprim, predominated (28%). In total, 77-9% of the
plasmids conferred resistance to other antibiotics raising the possibility that use
of any of these agents, not simply ampicillin, may contribute to the maintenance
of resistance genes.
INTRODUCTION
The normal commensal aerobic flora, in particular Escherichia coli, of healthy
populations is increasingly recognized as an important reservoir of antibiotic
resistance genes [1-6]. This is of considerable concern firstly, because commensal
gut bacteria may themselves cause endogenous infections and secondly, because
the resistance determinants may be transferred to any incoming pathogens
complicating the treatment of the subsequent infection [7].
Although a number of studies have elucidated the carriage of antibiotic
resistance determinants in the normal commensal flora, few have proceeded to
examine the genetic and biochemical mechanisms of such resistance in this specific
population. In contrast, the mechanisms of antibiotic resistance in clinical isolates
have been well investigated. The most important mechanism of resistance
identified to the most widely used class of antimicrobials, the /-lactam agents
[8, 9], is the production of /.-lactamases [10]. Amongst clinical isolates, TEM-1 is
* Author for correspondence.
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the most frequently isolated /3-lactamase [11, 12]. The ability of the TEM-1 gene
to mutate to both extended-spectrum /3-lactamases and inhibitor-resistant ,/-
lactamases is well documented raising the possibility that the normal commensal
flora may act not only as a reservoir of antibiotic resistance determinants to
current /3-lactam agents but also of new TEM-derived /3-lactamases as newer
agents are introduced into clinical practice. Indeed the implication that epidemic
TEM-1 plasmids in the community provide a source of new /3-lactamases has
recently been demonstrated in Edinburgh where TRC-1, a novel TEM-derived /3-
lactamase with increased resistance to /3-lactamase inhibitors, was found to be
present on an identical plasmid to a TEM-1 containing plasmid widespread within
the normal flora of the healthy community [13].
The plasmids on which resistance genes reside effect the levels of antibiotic
resistance in a given population; rapid rises in levels of resistance have been shown
to result from the spread of epidemic plasmids [14]. As a result, the need has been
emphasized for effective surveillance and classification of antibiotic resistance
plasmids in order to predict future resistance problems [14, 15]. There is, however,
little information currently available on genetic transfer of antibiotic resistance in
normal enteric flora which, as has been suggested previously, is likely to be the
source of resistance in enteric pathogens.
Amongst both clinical isolates and commensal isolates from healthy popu-
lations, the problems of antibiotic resistance in developing countries are major,
with much higher levels of resistance than found in Europe or the USA [16]. In
1992, a study of the prevalence of resistance to antimicrobials in faecal
Enterobacteriaceae of the healthy population in South Africa was conducted [5].
The survey examined eight separate population groups comprising infants (0-5
years), children (6-11 years), teenagers (12-19 years) and adults (> 19 years) from
four study areas. A high carriage rate of ampicillin resistance (886 %) amongst
this total population was revealed. In the current study, we investigated the
biochemical and genetic basis for transferable /3-lactam resistance amongst the 608
ampicillin resistant strains obtained.
METHODS
Identification of bacterial isolates
Bacterial colonies were identified by standard biochemical tests. Strains were
allocated into one of four groups: E. coli, Klebsiella spp., Enterobacter/Citrobacter
spp., or other Enterobacteria.
Conjugation studies
All the isolates were tested for the ability to transfer their resistance
determinants by the method of Amyes and Gould [17]. The conjugative
experiments employed the rifampicin-resistant E. coli K-12 J62-2 as the recipient.
Plasmid analysis
Plasmid DNA was extracted from 4'5 ml of overnight broth culture by a
modification of the procedure described by Takahashi and Nagano [18].
Restriction endonuclease digestion was performed with EcoR I for 4 h at 37 'C; an
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Table 1. Identification of transferable bacterial isolates
Total Transferable Transferable
Species number number percentage
E. coli 445 127 804
Klebsiella spp. 104 20 12 6
Enterobacter/Citrobacter spp. 35 3 19
Other 24 8 50 0
appropriate buffer was used according to the manufacturer's instructions (Gibco
BRL). Resultant DNA fragments were fractionated by electrophoresis at 60 V for
18 h on horizontal agarose gels (0 7 %), stained with ethidium bromide (50 mg/i),
visualized and photographed under ultraviolet light. A Hind III digest of phage
A was employed for gel calibration.
Antimicrobial sensitivity testing
The antibiogram of each transconjugant was determined by testing the strain's
sensitivity to a range of antimicrobials including amoxycillin (8 mg/l) and
amoxycillin plus clavulanic acid (8:4 mg/l) from SmithKline Beecham Pharma-
ceuticals, Surrey, UK, trimethoprim (10 mg/i) (from Wellcome Medical Division,
Crewe, UK), gentamicin (4 mg/i), spectinomycin (10 mg/i), streptomycin
(10 mg/i) and nalidixic acid (10 mg/i) all from Sigma Chemical Co. Ltd, Poole,
UK, cephaloridine (10 mg/1), cefuroxime (4 mg/i) and ceftazidime (2 mg/i) all
from Glaxo Group Research, Greenford, UK, cefotaxime (1 mg/i) (Roussel
Laboratories Limited, Uxbridge, UK), ciprofloxacin (1 mg/i) (Bayer, Newbury,
UTK), tetracyline (10 mg/l) (Lederle Laboratories, Gosport, UK) and chlor-
amphenicol (8 mg/i) (Boehringer Mannheim, East Sussex, UK). Serial dilutions
were made in single strength Davis and Mingioli medium (DM) [19] for each
overnight Isosensitest broth culture to give a 10 ' dilution. Of this bacterial
suspension, 2,tl was spotted onto a range of Isosensitest agar (Oxoid) plates
containing a single antibiotic at a given breakpoint value as recommended in the
BSAC guidelines [20]. All plates were incubated at 37 °C for 18 h. The control
strains employed were Pseudomonas aeruginosa NCTC 10662, Staphylococcus
aureus NCTC 6571 and Escherichia coli NCTC 10418. MICs were determined by
following the same method as for the antibiogram except that the test plates
contained serial doubling concentrations for the antibiotic as recommended in the
BSAC guidelines [20]. The MIC was defined as the lowest concentration on which
there was no visible growth after overnight incubation at 37 'C.
Preparation and analysis of /3-lactamaases
,8-lactamases for iso-electric focusing were prepared from bacterial colonies
grown overnight on 10 ml nutrient agar slopes and resuspended in 1 ml sodium
phosphate buffer (50 mm, pH 7 0). The cells were disrupted by ultrasonication
(8 ,tm, 2 x 15 s separated with a 30 s break, Soniprep). Cell lysate was removed by
centrifugation for 10 min at 4 'C at high speed (MSE Micro Centaur). Iso-electric
focusing was performed by the method of Matthew and colleagues [21]; the
ampholine range used was pH 3 5-10. Iso-electric focusing was carried out at 4 'C
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at 500 V and 20 mA, limited by constant power set at 1 W for 18 h (LKB 2197
Power pack). The standard /J-lactamase producing strains used as controls were
E. coli K12 J62-2 containing either plasmid RI (TEM-1), plasmid RP4 (TEM-2),
plasmid RIOIO (SHV-1) or plasmid R455 (OXA-1).
Specific activity of /3-lactamases
,3-lactamase production by strains was quantified with reference to the protein
concentration which was measured by the method of Waddell [22]. Nitrocephin
(50 ,tg/ml) was employed as the substrate.
RESULTS
Bacterial identification
The incidence of bacterial species amongst the ampicillin resistant isolates was
as follows: E. coli (73 %), Klebsiella spp. ( 17 %), Enterobacter/Citrobacter spp. (6 %)
and other Enterobacteria (4%).
Transfer of ampicillin resistance deternminants
Amongst the 608 isolates 158 (26%) were shown to contain self-transmissible
plasmids in conjugation studies [5]. The transferable strains were not restricted to
one species although E. coli was found to predominate (80-4%) (Table 1). As
shown in Table 2, a particularly high carriage rate of transferable strains (74%)
was identified amongst the infants in study area 1.
Transconjugant antibiograms
In addition to ampicillin, resistance to other antibiotics occurred at the
following frequencies: trimethoprim (48-7 %), streptomycin (35 4%), tetracycline
(27-2 %), spectinomycin (9 5 %), chloramphenicol (3-2 %) and gentamicin (I13%).
A total of 17 different antibiogram patterns was identified amongst all
transconjugants (Table 3). The most frequently identified antibiotic resistance
profile to be transferred was that of ampicillin and trimethoprim which accounted
for 45 (28f5%) of the antibiograms. Ampicillin alone was also a very common
resistance profile being found in 35 (22-2 %) of the transconjugants. Three other
resistance patterns, those of ampicillin and tetracycline, ampicillin and strep-
tomycin, and ampicillin, trimethoprim and streptomycin were repeatedly
recognized in 14, 15 and 16 of the transconjugants respectively. The 12 other
resistance patterns shown in Table 3 were isolated much less frequently, between
one and six occasions. None of the transconjugants could confer resistance to
amoxycillin plus clavulanic acid, cephaloridine, cefuroxime, cefotaxime,
ceftazidime, nalidixic acid or ciprofloxacin.
Plasmid analysis
The plasmids were extracted from the transconjugants and investigated by
endonuclease restriction analysis with EcoR I. Plasmids were assigned to a
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Table 2. Numbers and proportions of gram-negative isolates from different
pop tlation groups which transferred antibiotic resistance genes
Study area/
population group
Study area 1: Shongwe
Infants
Adults
Study area 2: Kagiso
C(hildren
Teenagers
Study area 3: Soweto
Infants
Adults
Study area 4: Hekpoort
Children
Teenagers
Total number
of isolates
81
112
54
82
80
80
66
53
Total number of
transconjugants
60
12
17
9
22
11
16
11
Table 3. Prevalence of different antibiogram
Number of
transconjugant
profiles amongst the transconjugants
Number of different
-Is restriction
Antibiogram* (percentage) patterns
Ap 35 (222) 25
ApSm 15 (95) 10
ApTc 14 (8 9) 5
ApTp 45 (285) 20
ApSmSp 2 (1.2) 2
ApSmTc 6 (38) 5
ApSmTp 16 (101) 10
ApSpTc 4 (25) 4
ApSpTp 2 (1.2) 2
ApCmSmTc 1 (06) 1
ApSmSpTc 3 (1-8) 3
ApSmTcTp 3 (1.8) 3
ApSpTcTp 5 (32) 5
ApCmGmTcTp 2 (1.2) 1
ApCmSmSpTc 1 (06) 1
ApCmSmTcTp 1 (06) 1
ApSmSpTcTp 3 (1.8) 3
* Ap, ampicillin; Sm, streptomycin; Tc, tetracycline; Tp, trimethoprim; Sp, spectinomycin;
Cm, chloramphenicol; Gm, gentamicin.
number of groups based on the restriction digest pattern. Plasmid profiles were
considered closely related and assigned to the same group if they differed by no
more than two bands. If the plasmids differed by three bands or more, they were
assigned to a separate group. Among the 158 ampicillin resistant transconjugants,
a total of 101 different plasmid profiles was identified. For each plasmid the
plasmid size (kb) was determined. In addition the number of occasions a single
plasmid type was isolated was recorded. Ten plasmids types were isolated on three
or more occasions and were subsequently termed 'common' plasmids (Table 4;
Fig. 1). Five of these 'common' plasmids originated in the isolates obtained from
IPereentage
74
10
31
11
27
14
24
20
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Table 4. Profile of the 'common' plasmids isolated from the transconjugants
pUK Number of
number transconjugants
Plasmid
size (kb)
Study area/
Antibiogram population group
64 Ap
134 ApTe
47 ApTp
60 ApSmTp
67 Ap
41 ApSm
48 ApSmTp
79 ApTp
48 Ap
63 ApTp
1-Infants
1-Infants
1-Infants
3-Infants
2-Children
4-Children
3-Infants/Children
1-Infants
2-Children
1 I-nfants
Fig. 1. Endonuclease restriction of 'common' plasmids in the transconjugants. Lane
1, pUK2409; lane 2, pUK2403; lane 3, pUK2404; lane 4, pUK2407; lane 5., pUK2406;
lane 6, pUK2405; lane 7, pUK2401; lane 8, pUK2400; lane 9, pUK2408; lane 10,
pUK2402; lane 11, A pre-cut with Hind III.
2400
2401
2402
2403
2404
2405
2406
2407
2408
2409
14
9
7
4
4
4
3
3
3
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infants in study area 1 (Fig. 1, lanes 4, 5, 7, 8 10). The maximum number of
occasions a single plasmid type was identified was 14 (89%). This plasmid, also
identified in infants from study area 1, is represented by pUK2400 (Fig. 1, lane 8),
was estimated as being 64 kb in size and was found to confer resistance to
ampicillin alone (Table 4). The second most common plasmid, again from infants
from study area 1, occurred in nine (5 7%) isolates and is represented by pUK2401
(Fig. 1, lane 7). This plasmid was identified as being 134 kb in size but in addition
to ampicillin, was found to mediate resistance to tetracycline (Table 4). The eight
other 'common' plasmids ranged in size from 41 kb to 79 kb. Only one 'common'
plasmid, represented by pUK2406 (Fig. 1, lane 5), resided in more than one
population group. This plasmid was identified in both infants and children from
study area 3.
There was a wide diversity in endonuclease restriction profile amongst those
plasmids isolated on less than three occasions; plasmids ranged in size from 12 kb
to 178 b. There was no correlation observed between the size of the plasmid and
the number of resistance determinants that it carried; 20 plasmids were larger
than 100 kb, yet the number of resistance determinants carried by them ranged
from one to five. While 74 plasmids encoded two resistance determinants, 35, 30
and 19 plasmids were found to encode 1, 3 and > 3 resistance determinants
respectively.
/3-lactamase analysis and distribution
The different ,3-lactamases responsible for mediating resistance to ampicillin
amongst the transconjugants were separated by iso-electric focusing. The TEM-1
/3-lactamase was the most frequently isolated ,-lactamase accounting for 943%
of the plasmid-encoded /l-lactamases. TEM-2 ,3-lactamase was found in four
(25 %) of the transconjugants while SHV-1 was identified in five (32%) of the
transconjugants. While it is recognized that some extended-spectrum ,-lactamases
focus at or near the same pl value as TEM- 1, TEM-2 or SHV- 1, the antibiotic
sensitivity testing results revealed these enzymes lacked any extended-spectrum
activity. The plasmids encoding TEM-2/,-lactamase all conferred resistance to
ampicillin alone. Two of these plasmids were identical in endonuclease restriction
profile, a third plasmid exhibited a similar profile while the fourth plasmid was
completely unrelated in endonuclease restriction profile. In contrast, the five
transconjugants containing plasmids encoding the SHV-1 ,3-lactamase exhibited
a complete diversity of antibiogram and restriction profiles.
Specific activity of the TEMl-1 /-lactamase and resistance to clavulanic acid
There has been concern over the emergence of strains resistant to ,3-lactam//3-
lactamase inhibitor combinations as a result of increased production of TEM-I.
The specific activity of the TEM-1 /8-lactamase isolated from the transconjugants
was determined and was found to range from 0-001-0-729 ,umol nitrocephin
hydrolysed/min/mg protein. The MICs of amoxycillin and amoxycillin plus
clavulanic acid in the transconjugants, were also ascertained. In the trans-
conjugants the MIC of amoxycillin varied between 256 mg/l and > 1024 mg/l
while the MIC of amoxycillin plus clavulanic acid varied between 2 mg/l and
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8 mg/I. No significant correlation was found, between the MIC of amoxycillin or
the MIC of amoxycillin plus clavulanic acid and the specific activity of the ,-
lactamase.
DISCUSSION
Increasing evidence suggests that the normal commensal flora of the healthy
individual, in particular E. coli, may act as the largest reservoir of antibiotic
resistance determinants. A number of studies have demonstrated that in this
specific bacterial population, as with clinical isolates, the carriage of antibiotic
resistant determinants is higher in developing than developed countries [23].
Until now there have been few investigations into the genetic and biochemical
basis of the development and spread of resistance amongst the non-pathogenic
commensal flora of healthy populations. The value of such studies is obvious if we
wish to assess whether the resistance genes and plasmids in the normal flora are
the progenitors of those encountered in clinical isolates.
In a previous study, the prevalence of antibiotic resistance in commensal
isolates from healthy black populations in' South Africa was assessed [5]. In the
current study these bacterial strains were investigated further; the ,-lactamases
responsible for transferable ampicillin resistance and the genetic carrier for this
resistance were identified. In particular, we wished to establish whether the
genetics of the ampicillin resistance genes differed from those found in commensal
bacteria in Scotland [6]. This was because the black populations studied in South
Africa form part of a different social structure from that of northern Europe,
probably living in conditions more closely resembling those of a developing
country except that water supplies were generally pure [5].
Amongst the 158 transconjugants, restriction endonuclease fingerprinting
identified 101 different plasmid types. Interestingly, five of 10 'common' plasmids,
that is plasmids occurring on three or more occasions, were identified in one
specific population group (infants in study area 1). Perhaps surprising was the lack
of more common' plasmids in infants from study area 3. As described in some
detail in the previous study [5], 20 of the specimens from this group were supplied
from infants attending one childminder. Previous surveys have indicated an
association between the presence of a common plasmid and children attending day
care centres [24]. Apart from a single plasmid type represented by pUK2406 which
was identified in two population groups, that is amongst both infants and children
from study area 3, the different plasmid types appeared to be restricted to specific
population groups. Analysis of ampicillin-resistant isolates from the healthy
community in Scotland identified a completely different situation, showing an
epidemic plasmid widely dispersed across various population groups [6]. Antibiotic
resistance determinants may disseminate as a result either of the clonal spread of
epidemic strains or the spread of epidemic plasmids, as in Scotland, or,
alternatively resistance genes may migrate to may different strains and plasmids
by transposition [8]. The latter appears to be happening in South Africa because
in this study the discovery of the fp-lactamase gene on such a wide variety of
plasmids suggests that ampicillin resistance is not simply the result of the spread
of one particular strain or plasmid. As the TEM-1 ,I-lactamase gene resides on
transposons, the gene is able to spread and be independently acquired through a
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series of transposition and integration events. Why it should be different from the
situation in Scotland is unclear. Limited hygiene and sanitation are conditions in
developing countries which may be more conducive to the spread of individual
genes ratiher than epidemic strains [25].
The predominance of TEM-1 as the determinant of ,J-lactam resistance amongst
clinical isolates has been extensively reported [26, 27]. From this and other
studies, it is now apparent, and perhaps not surprising, that the TEM-1 /3-
lactamase is largely responsible for ,3-lactam resistance amongst the commensal
faecal flora of healthy populations [6, 25]. The clinical implications of the
widespread presence of TEM-1 amongst isolates from the healthy population is of
concern. In recent years the TEM-1 /,-lactamase has shown a remarkable capacity
to cope with changes in antibiotic selective pressure. Indeed TEM-1 is recognized
as the progenitor of many extended-spectrum and inhibitor resistant ,-lactamases
which, from clinical experience have been shown to be selected in the presence of
newer cephalosporins and /3-lactam//,-lactamase inhibitor combinations
[13. 28, 29]. The potential exists for extended-spectrum /,-lactamases to appear
amongst the healthy community as oral later generation cephalosporins are
introduced into general practice. Although it has been argued that oral
cephalosporins are no more likely to select out extended-spectrum ,3-lactamases
than their parenteral counterparts [30], the threat of these new compounds lies in
their increased usage.
Previous studies have shown that the MICs of amoxycillin and amoxycillin plus
clavulanic acid are dependent on the amount of TEM-1 /3-lactamase synthesized
by clinical isolates [26, 31]. It has been suggested that this is not the only factor
determining the degree of resistance and that permeability, affinity for penicillin
binding proteins and overproduction of the chromosomal enzyme may each
contribute [31]. In order to overcome these influences in one study, the TEM-1
gene was transferred into an isogenic background. A clear correlation between the
specific activity of the /3-lactamase and the level of resistance was identified [261.
In contrast, in the current study, analysis of the transconjugants revealed no
obvious relationship between the specific activity of the TEM-1 ,3-lactamase and
the level of resistance to amoxycillin and amoxycillin plus clavulanic acid.
This study has demonstrated for the first time the presence of SHV- 1 and TEM-
2 /3-lactamases in the commensal faecal flora of healthy populations. TEM-2 was,
however, found on a restricted plasmid range. As the occurrence of these /3-
lactamases was rare, it is not clear if they will persist in the community or if TEM-
1 /3-lactamase will replace them. This study has also confirmed the successful
nature of the TEM- 1 /3-lactamase in this specific bacterial population. The
detrimental impact that TEM-1 may have on the healthy community is twofold.
Not only will current therapy be complicated by the presence of this enzyme but
in addition, as newer cephalosporins and /-lactam//l-lactamase inhibitor com-
bination agents are introduced into general practice, the presence of TEM-1
provides the opportunity for the selection of extended-spectrum and inhibitor-
resistant /8-lactamases that are able to render these newer agents ineffective.
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